Airmid   Phone: (650) 368 6983

Multiple sclerosis

Multiple sclerosis is a disease caused by autoimmune damage to the central nervous system including the brain, which affects roughly two and a half million people worldwide. Symptoms include muscle weakness and paralysis, and the disease can progress rapidly and unpredictably and may eventually lead to death.

Treatment usually includes the use of anti-inflammatory and immunosuppressive drugs which have potentially severe side effects. Animal models of Multiple sclerosis have been successfully treated using blockers of the Kv1.3 Potassium Channel, which selectively inhibit the function of effector memory T cells.

October 2016
October 2016 Press Release on KPI Therapeutics Presenting Positive Data at Skin Disease Conference
June 2016
June 2016 Press Release About Promising Results of Dalazatide in Lupus Study
June 2016 Fact Sheet: What Is Lupus?
January 2016
January 2016 Press Release on KPI Biotech Showcase
January 2016 Board Member George Miljanich passes
December 2015
December 2015 AIRMID Makes Board Changes
November 2015
November 2015 New Lupus Treatment Being Tested for Younger Patients